Influenza peptides and compositions

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 11439702
APP PUB NO 20200397889A1
SERIAL NO

17013000

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present specification discloses recombinant nucleic acid constructs encoding an immunogenic multiepitope polypeptide comprising two or more polypeptides, recombinant nucleic acid constructs encoding at least two epitopes from two or more internal proteins of influenza virus, compositions comprising such recombinant nucleic acid constructs and methods of eliciting a T cell immune response against an influenza virus in a vertebrate using such recombinant nucleic acid constructs and compositions.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
PEPTCELL LIMITED100 FETTER LANE LONDON EC4A 1BN

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Caparros-Wanderley, Wilson Romero Buckinghamshire, GB 17 120
Stoloff, Gregory A London, GB 20 129

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Mar 13, 2026
7.5 Year Payment $3600.00 $1800.00 $900.00 Mar 13, 2030
11.5 Year Payment $7400.00 $3700.00 $1850.00 Mar 13, 2034
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00